The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Cure of duodenal ulcer associated with eradication of Helicobacter pylori
Abstract
50 patients with intractable duodenal ulcer were randomly assigned to 4 weeks of treatment with colloidal bismuth subcitrate (CBS) alone (26 patients) or with amoxicillin and metronidazole (24 patients). 5 patients (all on triple therapy) withdrew because of side-effects. In 17 of the 45 patients who completed the treatment, Helicobacter pylori was eradicated, and there was no ulcer relapse during the first 12 months of follow-up. The ulcer relapse rate was significantly higher (17 of 21 [89%]) among patients who remained positive for H pylori. 9 patients who remained positive for H pylori and had ulcer relapses within 6 months of treatment with CBS alone, were subsequently given triple therapy. 7 of the 9 showed H pylori eradication and no relapses within the next 12 months. The 2 patients still H pylori-positive after triple therapy had further ulcer relapses. H pylori eradication, without altering acid output, will become the mainstay of duodenal ulcer treatment because it cures the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A final piece of evidence was demonstration that antibiotics alone, without H2 blockers or PPIs, could cure ulcers [17–20].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [20]
Citations
Cites
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
Marshall, B., & Warren, J. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91816-6 · Cited by 5,509
Manual for the identification of medical bacteria.
Cowan, S. T., & Steel, K. (1965) · Cambridge University Press eBooks · Cited by 4,823
Attempt to fulfil Koch's postulates for pyloric Campylobacter
Marshall, B. J., Armstrong, J. A., McGechie, D. B., & Clancy, R. J. (1985) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1985.tb113443.x · Cited by 1,307
PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI
Marshall, B. J., Warren, J. R., Blincow, E., Phillips, M. R., Goodwin, C. S., Murray, R., Blackbourn, S., Waters, T. E., & Sanderson, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90929-4 · Cited by 1,035
Campylobacter pyloridis-associated chronic active antral gastritis
Rauws, E. A., Langenberg, W., Houthoff, H. J., Zanen, H. C., & Tytgat, G. N. J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90606-3 · Cited by 796
Self-citationIngestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.
Morris, A., & Nicholson, G. I. (1987) · PubMed · Cited by 750
CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDY
Coghlan, G., Humphries, H., Dooley, C. P., Keane, C. T., Gilligan, D., Mckenna, D., Sweeney, E., & O'Morain, C. A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91545-5 · Cited by 539
CAMPYLOBACTER-UKE ORGANISMS IN THE STOMACH OF PATIENTS AND HEALTHY INDIVIDUALS
Langenberg, M. L., Tytgat, G. N. J., Schipper, M. E. I., Rietra, P. J. G. M., Zanen, H. C., Burnett, R. A., Forrest, J. A. H., Girdwood, R. W. A., & Fricker, C. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91836-1 · Cited by 290
Self-citationJones, D. B., Howden, C. W., Burget, D. W., Kerr, G. D., & Hunt, R. H. (1987) · Gut · doi:10.1136/gut.28.9.1120 · Cited by 280
Martin, D., May, S., Tweedle, D. F., Hollanders, D., Ravenscroft, M., & Miller, J. P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90114-8 · Cited by 262
Research works printed but not linked: 3
- Lambert, 1987, Effect of colloiad bismuth (De-Nol) and healing relapse of duodenal ulcer-role of Campylobacter pyloridis., Gastroenterology, 92, 1489
- Borody, 1988, Long term Campylobacter pylori recurrence post-eradication, Gastroenterology, 94, 43
- Smith, 1988, A comparison of ranitidine and tripotassium dicitrato-bismuth (TDB) in relapse rate of duodenal ulcer. The role of Campylobacter pylori, Gastroenterology, 94, 431
Cited by
Sorted by citations
Items 201–300 of 908
Perceived stress as a risk factor for peptic ulcers: a register-based cohort study
Deding, U., Ejlskov, L., Grabas, M. P. K., Nielsen, B. J., Torp-Pedersen, C. T., & Bøggild, H. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0554-9 · Cited by 60
Ernst, P. B., & Gold, B. D. (1999) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199905000-00005 · Cited by 60
Helicobacter pylori Infection and the Pathogenesis of Duodenal Ulceration
Walker, M. M., & Crabtree, J. E. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb11114.x · Cited by 60
Miyaji, H., Azuma, T., ITO, S., Suto, H., Ito, Y., Yamazaki, Y., Sato, F., Hirai, M., Kuriyama, M., Kato, T., et al. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00258.x · Cited by 60
McGavock, H., Webb, C. H., Johnston, G. D., & Milligan, E. (1993) · BMJ · doi:10.1136/bmj.307.6912.1118 · Cited by 60
Treating Bugs with Bugs: The Role of Probiotics as Adjunctive Therapy for Helicobacter pylori
Wilhelm, S. M., Johnson, J. L. H., & Kale-Pradhan, P. B. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1q104 · Cited by 60
Helicobacter pylori infection and gastric juice vitamin C levels
Rokkas, T., Papatheodorou, G., Karameris, A., Mavrogeorgis, A., Kalogeropoulos, N., & Giannikos, N. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02064380 · Cited by 59
Lam, S., Ching, C., Lai, K. C., Wong, B. C. Y., Lai, C., Chan, C. K., & Ong, L. H. Y. (1997) · Gut · doi:10.1136/gut.41.1.43 · Cited by 59
In Vitro Anti- Helicobacter pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-1657
Akada, J. K., Shirai, M., Fujii, K., Okita, K., & Nakazawa, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1072 · Cited by 59
Oksanen, A. M., Veijola, L., Sipponen, P., Schauman, K., & Rautelin, H. I. K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.955-957.1998 · Cited by 59
Schöttker, B., Adamu, M. A., Weck, M. N., & Brenner, H. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.12.036 · Cited by 58
Psychosocial factors in peptic ulcer and inflammatory bowel disease.
Levenstein, S. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.70.3.739 · Cited by 58
Cigarette smoking and Helicobacter pylori infection
Bateson, M. C. (1993) · Postgraduate Medical Journal · doi:10.1136/pgmj.69.807.41 · Cited by 58
Beardshall, K., Moss, S. F., Gill, J., Levi, S., Ghosh, P., Playford, R. J., & Calam, J. (1992) · Gut · doi:10.1136/gut.33.5.601 · Cited by 58
Duodenal ulcer: the villain unmasked?
Axon, A. (1991) · BMJ · doi:10.1136/bmj.302.6782.919 · Cited by 58
Ladabaum, U., Chey, W. D., Scheiman, J. M., & Fendrick, A. M. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01306.x · Cited by 57
de Broek, N. T. L.-V., Numans, M. E., Buskens, E., Verheij, T. J., de Wit, N. J., & Smout, A. J. P. M. (2001) · Europe PMC (PubMed Central) · Cited by 57
In vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori
Tominaga, K. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf159 · Cited by 56
History of Perforated Duodenal and Gastric Ulcers
Lau, W. Y., & Leow, C. K. (1997) · World Journal of Surgery · doi:10.1007/s002689900323 · Cited by 56
Logan, R., Bardhan, K. D., Celestin, L.-C., Theodossi, A., Palmer, K. R., Reed, P. I., Baron, J. H., & Misiewicz, J. J. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00400.x · Cited by 56
Precise role ofH pyloriin duodenal ulceration
HOBSLEY, M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i40.6413 · Cited by 55
Helicobacter pyloriand Peptic Ulcer Disease
van der Hulst, R. W. M., & Tytgat, G. N. J. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609094744 · Cited by 55
Self-citationLouw, J. A., Lucke, W., Jaśkiewicz, K., Lastovica, A. J., Winter, T. A., & Marks, I. N. S. (1995) · Gut · doi:10.1136/gut.36.4.544 · Cited by 55
Seppälä, K., Färkkilä, M. A., Nuutinen, H. U., Hakala, K., Väänänen, H., Rautelin, H. I. K., & Kosunen, T. U. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209000173 · Cited by 55
Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections
Sandvik, A. K., Waldum, H. L., & Brenna, E. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.1.29 · Cited by 54
Helicobacter pylori Infections
Marshall, B. J., & Gilman, R. H. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00023-9 · Cited by 54
Histamine H2-Receptor Antagonists in Peptic Ulcer Disease
Nash, J., Lambert, L., & Deakin, M. (1994) · Drugs · doi:10.2165/00003495-199447060-00002 · Cited by 54
Heteroresistance of Helicobacter pylori from the same patient prior to antibiotic treatment
Kao, C., Lee, A.-Y., Huang, A.-H., Song, P.-Y., Yang, Y., Sheu, S., Chang, W.-L., Sheu, B., & Wu, J.-J. (2014) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2014.02.009 · Cited by 53
Xia, H. H., Wong, B. C. Y., Wong, K. W., Wong, S., Wong, W. M., Lai, K. C., Hu, W., Chan, C. K., & Lam, S. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01115.x · Cited by 53
HELICOBACTER PYLORI AND PEPTIC DISEASE IN THE PEDIATRIC PATIENT
Bujanover, Y., Reif, S. S., & Yahav, J. (1996) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70403-x · Cited by 53
Sung, J. J. �., Leung, W. K., Suen, R., Leung, V. K. S., Chan, F. K. L., Ling, T. K. �., Lau, J. Y. W., Lee, Y. T., Ng, E. K., Cheng, A. F., et al. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018816729449 · Cited by 53
Sharma, V. K., Sahai, A. V., Corder, F. A., & Howden, C. W. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01134.x · Cited by 53
Take, S., Mizuno, M., Ishiki, K., Imada, T., Okuno, T., Yoshida, T., Yokota, K., Oguma, K., Kita, M., Okada, H., et al. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0536-9 · Cited by 52
Arkkila, P. E. T., Seppälä, K., Kosunen, T. U., Haapiainen, R. K., Kivilaakso, E. O., Sipponen, P., Mäkinen, J., Nuutinen, H. U., Rautelin, H. I. K., & Färkkilä, M. A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00667-1 · Cited by 52
One week's anti-Helicobacter pylori treatment for duodenal ulcer.
Logan, R., Gummett, P. A., Misiewicz, J. J., Karim, Q. N., Walker, M. M., & Baron, J. H. (1994) · Gut · doi:10.1136/gut.35.1.15 · Cited by 52
Indications for treatment of Helicobacter pylori infection: a systematic overview.
van Zanten, S. J. V., & Sherman, P. M. (1994) · Europe PMC (PubMed Central) · Cited by 52
Possible Mechanisms and Mediators of Gastritis Associated withHelicobacter pyloriInfection
Wallace, J. L. (1991) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529109098226 · Cited by 51
The Role of Helicobacter pylori in Acid-Peptic Disease
DeCross, A. J., & Marshall, B. J. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199312000-00006 · Cited by 51
Accuracy of Diagnostic Tests for Helicobacter pylori in Patients with Peptic Ulcer Bleeding
Choi, Y. J., Kim, N., Lim, J., Jo, S. Y., Shin, C. M., Lee, H. S., Lee, S. H., Park, Y. S., Hwang, J., Kim, J., et al. (2012) · Helicobacter · doi:10.1111/j.1523-5378.2011.00915.x · Cited by 50
Georgopoulos, S. D., Ladas, S. D., Karatapanis, S., Mentis, A. F., Spiliadi, C., Artikis, V., & Raptis, S. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005405209503 · Cited by 50
Urea Breath Tests for the Detection of Helicobacter pylori Infection
Bazzoli, F., Zagari, M., Fossi, S., Pozzato, P., Ricciardiello, L., Mwangemi, C., Roda, A., & Roda, E. (1997) · Helicobacter · doi:10.1111/j.1523-5378.1997.06b10.x · Cited by 50
No Helicobacter pylori, no Helicobacter pylori‐associated peptic ulcer disease
Tytgat, G. N. J. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00782.x · Cited by 50
Self-citationBell, G. D., Bate, C. M., Axon, A. T. R., Tildesley, G., Kerr, G. D., Green, J. R. B., Emmas, C., & TAYLOR, M. D. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00414.x · Cited by 50
Isolation of a Genetic Locus Associated with Metronidazole Resistance inHelicobacter pylori
Chang, K., Ho, S., Yang, J., & Wang, J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7050 · Cited by 50
Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase proteinin vivo
Gabay, C., Gigley, J. P., Sipe, J. D., Arend, W. P., & Fantuzzi, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200102)31:2 · Cited by 61
Wong, Lam, 。., LAI, Hu, Ching, Ho, P., Yuen, Chan, S. O., Lau, & LAI (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00477.x · Cited by 49
Kamada, T., Haruma, K., Komoto, K., Mihara, M., Chen, X., Yoshihara, M., Sumii, K., Kajiyama, G., Tahara, K., & Kawamura, Y. (1999) · Helicobacter · doi:10.1046/j.1523-5378.1999.99299.x · Cited by 49
Mossi, S., Meyer-Wyss, B., Renner, E. L., Merki, H. S., Gamboni, G., & Beglinger, C. (1993) · Gut · doi:10.1136/gut.34.6.752 · Cited by 49
Kawakami, E., Ogata, S. K., Portorreal, A., Magni, A. M., Escobar-Pardo, M. L., & Patrício, F. R. S. (2001) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032001000300011 · Cited by 48
Marshall, B. J. (2006) · ChemMedChem · doi:10.1002/cmdc.200600153 · Cited by 48
Sarker, S. A., Mahalanabis, D., Hildebrand, P., Rahaman, M., Bardhan, P. K., Fuchs, G. J., Beglinger, C., & Gyr, K. E. (1997) · Clinical Infectious Diseases · doi:10.1086/516070 · Cited by 48
The Role ofHelicobacter pyloriin Peptic Ulcer Disease
O'Connor, H. J. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409105354 · Cited by 48
Helicobacter pylori lipopolysaccharide stimulates gastric mucosal pepsinogen secretion
Young, G. O., Stemmet, N., Lastovica, A. J., der Merwe, E. L. V., Louw, J. A., Modlin, I. M., & Marks, I. N. S. (1992) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1992.tb00260.x · Cited by 48
McMahon, B. J., Bruce, M. G., Hennessy, T. W., Bruden, D. L., Sacco, F. D., Peters, H. V., Hurlburt, D. A., Morris, J. M., Reasonover, A. L., Dailide, G., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02880.x · Cited by 47
Helicobacter pylori risk associated with childhood home environment
Ueda, M., Kikuchi, S., Kasugai, T., Shunichi, T., & Miyake, C. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01375.x · Cited by 47
Gastric secretion and peptic ulceration in cirrhosis
Fraser, A. G., Pounder, R. E., & Burroughs, A. K. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80191-6 · Cited by 47
The killing of Helicobacter pylori by low-power laser light in the presence of a photosensitiser
Millson, C., Wilson, M., MacRobert, A. J., Bedwell, J., & Bown, S. G. (1996) · Journal of Medical Microbiology · doi:10.1099/00222615-44-4-245 · Cited by 47
Histamine H2-Receptor Antagonists in Peptic Ulcer Disease
Deakin, M., & Williams, J. G. (1992) · Drugs · doi:10.2165/00003495-199244050-00003 · Cited by 47
Sanders, S. (1996) · Clinical Therapeutics · doi:10.1016/s0149-2918(96)80175-5 · Cited by 47
Reilly, T. G., Ayres, R., Poxon, V., & Walt, R. P. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00410.x · Cited by 47
Seppälä, K., Pikkarainen, P. H., Sipponen, P., Kivilaakso, E. O., & Gormsen, M. (1995) · Gut · doi:10.1136/gut.36.6.834 · Cited by 47
Helicobacter pylori in 205 Consecutive Endoscopy Patients
Befrits, R., Granström, M., Rylander, M., & Rubio‐Terres, C. (1993) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549309008483 · Cited by 47
Quality of Life and Relapse of Duodenal Ulcer before and after Eradication of Helicobacter pylori
Wilhelmsen, I., & Berstad, A. (1994) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529409094856 · Cited by 47
Bruce, M. G., Bruden, D. L., McMahon, B. J., Hennessy, T. W., Reasonover, A. L., Morris, J. M., Hurlburt, D. A., Peters, H. V., Sacco, F. D., Martinez, P., et al. (2006) · Helicobacter · doi:10.1111/j.1523-5378.2006.00462.x · Cited by 46
Wong, W. M., Wong, B., Lü, H., Gu, Q., Yin, Y., Wang, W. H., Fung, F. M. Y., Lai, K. C., Xia, H. H., Xiao, S. D., et al. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01223.x · Cited by 46
Furuta, T., Kaneko, E., Suzuki, M., Arai, H., & Futami, H. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.10.2421-2425.1996 · Cited by 46
Hirai, M., Azuma, T., Ito, S., Kato, T., Kohli, Y., & Fujiki, N. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560111 · Cited by 46
Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients
Ford, A. C., Delaney, B. C., Forman, D., & Moayyedi, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003840.pub2 · Cited by 46
Helicobacter pylori infection: approach of primary care physicians in a developing country
Ahmed, S., Salih, M., Jafri, W., Shah, H. A., & Hamid, S. S. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-23 · Cited by 45
Prasad, S., Mathan, M. M., Chandy, G. M., Rajan, D. P., Venkateswaran, S., Ramakrishna, B., & Mathan, V. I. (1994) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1994.tb01281.x · Cited by 45
Debets-Ossenkopp, Y. J., Namavar, F., & MacLaren, D. M. (1995) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02116532 · Cited by 45
Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori
Millar, M. R., & Pike, J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.185 · Cited by 45
Harvey, R. F. (2002) · QJM · doi:10.1093/qjmed/95.8.519 · Cited by 44
Absence of dyspeptic symptoms as a test for Helicobacter pylori eradication: Table 1
Phull, P. S., Halliday, D., Price, A. B., & Jacyna, M. R. (1996) · BMJ · doi:10.1136/bmj.312.7027.349 · Cited by 44
Kikuchi, S., Kurosawa, M., & Sakiyama, T. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00504.x · Cited by 44
One-day therapy for treatment ofHelicobacter pylori infection
Tucci, A., Corinaldesi, R., Stanghellini, V., Paparo, G. F., Gasperoni, S., Biasco, G., Varoli, O., Maccarini, M. R., & Barbara, L. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303176 · Cited by 44
Gastric Epithelial Cells in Helicobacter pylori‐Associated Gastritis Express HLA‐DR but not ICAM‐1
Scheynius, A., & Engstrand, L. G. (1991) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1991.tb03755.x · Cited by 44
Effect of N-Acetyl Cysteine on Helicobacter pylori
Gürbüz, A. K., Özel, M., Öztürk, R., Yıldırım, Ş., Yazgan, Y., & Demırtürk, L. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000182486.39913.da · Cited by 43
Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori
Ito, I., Shibata, K., Hongo, A., & Kinoshita, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01622-1 · Cited by 43
Fock, Chelvam, & Lim, S. G. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00691.x · Cited by 43
Baena, J. M., López, C. O. G., Hidalgo, A., Rams, F. R., Jiménez, S., García, M., & Hernández, M. R. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200203000-00014 · Cited by 43
Porro, G. B., Parente, F., & Lazzaroni, M. (1993) · Gut · doi:10.1136/gut.34.4.466 · Cited by 43
Helicobacter pylori seroprevalence in patients with chronic bronchitis
Roussos, A., Tsimpoukas, F., Anastasakou, E., Alepopoulou, D., Paizis, I. A., & Philippou, N. (2002) · Journal of Gastroenterology · doi:10.1007/s005350200046 · Cited by 42
Rodriguez‐Torres, M., Salgado-Mercado, R., Ríos‐Bedoya, C. F., Aponte-Rivera, E., Marxuach-Cuétara, A. M., Rodr�guez-Orengo, J. F., & Fernández-Carbia, A. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2549-1 · Cited by 42
Novel Formulation Approaches to Oral Mucoadhesive Drug Delivery Systems
Akiyama, Y., & Nagahara, N. (1999) · Drugs and the pharmaceutical sciences · doi:10.1201/b14099-19 · Cited by 42
Eradication of Helicobacter pylori: a clinical update.
Romano, M., & Cuomo, A. (2004) · PubMed · Cited by 41
Helicobacter pylori in dental plaque and gastric mucosa
Cheng, L., Webberley, M. J., Evans, M., Hanson, N., & Brown, R. (1996) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/s1079-2104(96)80017-5 · Cited by 41
Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum.
Khulusi, S., Mendall, M. A., Badve, S., Patel, P., Finlayson, C., & Northfield, T. C. (1995) · Gut · doi:10.1136/gut.36.2.193 · Cited by 41
Helicobacter pyloriEradication with Doxycycline—Metronidazole—Bismuth Subcitrate Triple Therapy
Borody, T. J., George, L. L., Brandl, S., Andrews, P., Lenne, J., Moore‐Jones, D., Devine, M., & Walton, M. N. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209000075 · Cited by 41
Successful Helicobacter pylori eradication incorporating a one‐week antibiotic regimen
Hudson, N., Brydon, W. G., Eastwood, M. A., Ferguson, A., & Palmer, K. R. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00350.x · Cited by 41
A proton pump inhibitor, E3810, has antibacterial activity through binding toHelicobacter pylori
Hirai, M., Azuma, T., Ito, S., Kato, T., & Kohli, Y. (1995) · Journal of Gastroenterology · doi:10.1007/bf02347561 · Cited by 41
Helicobacter pylori cag Pathogenicity Island's Role in B7-H1 Induction and Immune Evasion
Lina, T. T., Alzahrani, S., House, J., Yamaoka, Y., Sharpe, A. H., Rampy, B. A., Pinchuk, I. V., & Reyes, V. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121841 · Cited by 40
Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital.
Vu, C., & Ng, Y. Y. (2000) · PubMed · Cited by 40
Helicobacter pylori infection in peptic ulcer haemorrhage
van Leerdam, M. E., & Tytgat, G. N. J. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.0160s1066.x · Cited by 40
Self-citationPilotto, A., Franceschi, M., Mario, F. D., Leandro, G., Bozzola, L., & Valerio, G. (1998) · Gerontology · doi:10.1159/000022000 · Cited by 40
Take, S., Mizuno, M., Ishiki, K., Nagahara, Y., Yoshida, T., Yokota, K., Oguma, K., Okada, H., & Yamamoto, K. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05606.x · Cited by 40
Serological detection of Helicobacter pylori by a flow microsphere immunofluorescence assay
Best, L. M., van Zanten, S. J. V., Bezanson, G., Haldane, D. J. M., & Malatjalian, D. A. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.9.2311-2317.1992 · Cited by 40
7 Helicobacter pylori in duodenal and gastric ulcer disease
Rauws, E. A., & Tytgat, G. N. J. (1995) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(95)90047-0 · Cited by 40
Self-citationOwen, R. J., Bickley, J., Hurtado, A., Fraser, A. G., & Pounder, R. E. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1203-1210.1994 · Cited by 40
Duodenal ulcer relapse after eradication of Helicobacter pylori
Fiocca, R., Solcia, E., & Santoro, B. (1991) · The Lancet · doi:10.1016/0140-6736(91)93316-2 · Cited by 40
Metadata
- Authors
- Rauws, E. A. J., & Tytgat, G. N. J.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Corresponding author
- Rauws, E.A.J.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1990-05
- Volume
- 335
- Issue
- 8700
- Pages
- 1233-1235
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2029865847
- Cited by
- 922
- References
- 23
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 12 · 2016: 13 · 2015: 10 · 2014: 18 · 2013: 11 · 2012: 14
- FWCI
- 106.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- duodenal ulcer, Helicobacter pylori eradication, bismuth subcitrate, amoxicillin, metronidazole, triple therapy, ulcer recurrence
- MeSH terms
- Administration, Oral, Amoxicillin, Anti-Ulcer Agents, Campylobacter, Campylobacter Infections, Drug Administration Schedule, Drug Evaluation, Drug Therapy, Combination, Duodenal Ulcer, Follow-Up Studies, Gastric Mucosa, Humans, Metronidazole, Organometallic Compounds, Prospective Studies, Recurrence, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review